M2M Unit 3 Flashcards
(215 cards)
5 properties of malignant cancer cells
- unresponsive to normal signals for proliferation control
- de-differentiated (lack many of the specialized structures/funcs of the tissues in which they grow)
- invasive (capable of outgrowth into neighboring normal tissues to extend the boundaries of the tumor)
- metastatic (capable of shedding cells that can drift through the circ sys and proliferate at other sites in the body)
- clonal in origin (derived from a single cell)
- **can measure transformation in a lab via increased anchorage independence
multi-step process for carcinogenesis
1- susceptibility to cancer is inherited- carcinogenesis is a multi-step process
–accumulation of somatic mutations produced by environmental factors over time
2-an early mutation may be in a DNA repair gene that increases the rate of more mutations
–ex. P53, BRCA1, BRCA2
3- tumor initiation (occurs via mutations in oncogenes and anti-oncogenes)
4- promotion
5- conversion
6-progression
2 types of genes usually mutated in tumor initiation and their effect on cellular proliferation
oncogenes- drive proliferation
- quantitative changes- overexpression (BCR/ABL)
- qualitative changes- create a hyperactive protein
anti-oncogenes- inhibit proliferation or metastasis
-tumor supressors
2 cytogenic abnormalities associated with malignancy
cytogenic analysis to study cancer gave first clues to genetic abnormalities in cancer cells and is used in clinical diagnosis
translocations and gene deletions may activate oncogenes or inactivate tumor supressors
-ex. Chronic myelocytic leukemia (CML) assoc w/ Philadelphia chr
inactivation of tumor supressors may occur by LOH
-ex. retinoblastoma and the APC gene in familial adenomatous polyposis (FAP)
events that can produce LOH
loss of a tumor supressor gene (loss of RB gene)
a tumor supressor gene can be transferred during recombination, leading to a gamete w/o the gene
LOH can occur via:
mutation, mitotic recombination, chromosome loss, environmental factors
Knudson’s theory
2 hits/events needed to acquire a cancer
1 hit-familial individuals already have 1 mutation and just need to lose 1
2 hit-acquired patients need 2 hits to have cancer
how are cancers associated with both dominant and recessive symptoms
susceptibility to cancer is inherited in both fashions
inherited in a dominant fashion: ex. susceptibility to Retinoblastoma
- heterozygotes are non-malignant, but will be cancerous w/ the loss of a single normal RB gene in 1 cell
- thus, RB heterozygotes are likely to develop disease and pass on the defective gene to 1/2 of children, thereby making retinoblastoma a dominant inheritance pattern
in reality- cells must be homozygous RB mutated to be malignant
describe how RB gene was first identified
cytogenic analysis of retinoblastoma cells showed the region around Chromosome 13q14 often had an abnormal structure
- retinoblastoma cells from some patients lack RB completely; both copies of RB have been deleted via PCR analysis
- some patients have partial deletions or other rearrangements of RB
RB protein’s function in the cell cycle and malignancy
RB protein is hyperphosphorylated in rapidly proliferating cells at S or G2 in cell cycle, but is hypophosphorylated in non-proliferating cells in G0 or G1
-hypophosphorylated form of RB protein normally functions to repress the entry of cells into the S phase. When RB becomes hyperphosphorylated, it no longer inhibits this transition and the cells begin a cell division cycle. Thus, when there is no RB protein or it is non-functional, cells cannot downregulate their cell division and grow out of control
RB protein general info
RB is an inhibitor of cell proliferation and is therefore an anti-oncogene or tumor supressor
phosphorylation by CDKs inactivates the RB protein, so cell proceeds from G1 to S phase
RB protein is a target for many animal tumor viruses
- ex. SV40 and HPV
- these viruses drive a quiescent cell into S phase and proliferate by producing a viral protein(s), SV40T antigen (transforming) or HPV E7 protein, that binds to and inactivates the RB protein
hallmark of a tumor supressor gene or anti-oncogene
relates to RB gene
hallmark: LOH and acquired Homozygosity for the susceptible gene
Inherited retinoblastoma: the DNA from the normal tissue of the patient or from another unaffected family member often shows a defect in the RB gene, but has one normal copy per cell.
In these patients it apperas that normal, nonmalignant retinal cells are heterozygotes for RB gene but the tumor cells have descended as a clone from a single cell that has acquired homozygosity for the RB susceptible gene
3 tumor suppressor genes
APC
BRCA1
BRCA2
how does APC function as a tumor supressor
APC is a tumor suppressor in FAP (familial adenomatous polyposis)
FAP is inherited via autosomal dominant- 1 defective APC gene puts you at high risk for colon cancer, but need 2nd mutation (LOH) to develop phenotype
APC gene encodes a cytoplasmic protein that regulates the localization of the beta-catenin in cytoplasm
beta-catenin is bound to E-cadherin at plasma membrane in mormal cells
APC protein cuases degradation of any unbound beta-catenin in cytoplasm
FAP patients lose APC, so beta-catenin goes to nucleus to produce (over) transcription of oncogenes like c-myc
how do BRCA1 and BRCA2 function as tumor suppressor genes
BRCA1 and BRCA2- predisposing genes for breast and ovarian cancer
inherited cases display LOH and have only 1 mutant gene
aquired- these genes haven’t been found in tumors, so it’s believed that mutations in other genes may affect BRCA functions indirectly
homozygous BRCA2 mutations get Fanconi’s anemia
heterozygotes get breast cancer from mammary gland losing the WT allele
describe why p53 was originally incorrectly thought to be an oncogene
initially thought to be an oncogene because certain p53 mutations were dominant to the WT gene in producing cellular transformation; tumors were still heterozygous
the explanation was found by showing that the oncogenic p53 mutations produce a mutant p53 protein that can bind the WT protein and inactivate it
“dominant negative” mutation spoils the WT protein
explain why p53 gene is the “guardian of the genome”
cells missing p53 accumulate mutations at a high rate and have a higher chance of becoming malignant
p53 prevents potentially deleterious mutations though the replication of damaged DNA, and introducing apoptosis in cells with too much damage
cellular function of p53 protein
important for cell response to environmental mutagenesis
acts as a transcription factor important for expression of genes- preventing cells from replicating damaged/foreign DNA
required for apoptosis- when cells commit suicide if their DNA is damaged beyond repair
p53 defective cells replicate DNA and produce mutations leading to cancer (mutant p53 found in ~50% all cancers)
-“hot spots”- common areas for point mutations
oncogenic viruses vs RB and p53
viruses have oncogenes that act by inactivating p53
viruses also inactivate RB protein
destruction of RB and p53 is a major route to cancer
ex of oncogenic virus in humans
HPV Human papilloma virus
HPV E7 binds to RB and deactivates it
HPV E6 binds p53 and causes it to be degraded
how were oncogenes discovered
discovered oncogenes in certain oncogenic retroviruses from animals (chicken)
with 1 particular viral gene segment (v-onc), tumors are rapidly induced in the infected cells
w/o it, integration into host genome occurs w/o activation of oncogenes
method:
put cells in agar, watch for proliferation
normal cells- no anchorage to grow, so no proliferation
infected cells- proliferate regardless of anchorage
define retrovirus
RNA containing membrane-enclosed viruses that bud from cell membrane of infected cells and usually don’t kill infected cell
examples of oncogene discovery
v-src
v-erb
v-abl
v-myc
V-src; oncogene of Rous Sarcoma Virus; caused fibrosarcomas in certain birds
V-erb: oncogene of avian erythroblastosis virus; causes erythroblastosis in chickens
V-abl- oncogene found in Abelson leukemia virus from mice
V-myc- gene usually fused with a portion of the gag gene (in RNA); appears this gene is capable of eliciting neoplastic transformation of cells
protein products of viral oncogenes-
pp60v-src protein
coded by v-src gene is a membrane bound protein kinase that phosphorylates tyrosine residues in several different proteins. The proteins change cell properties by affecting gene expression
protein products of viral oncogenes-
v-erb-B
codes for a protein that is similar in structure to the cell surface receptor for epidermal growth factor (EGFR). This raises the possibility that this protein has growth stimulating properties like EGFR. This receptor is a member of a family of related proteins that exhibit tyrosine-specific protein kinase activity